ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

NCI Plans Network for Providing Access To Pathology Information Over The Web

November 12, 1999

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

Kansas Gov. Sebelius Nominated For HHS

March 6, 2009